A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Sang Joon | - |
dc.contributor.author | Lee, Jeeyun | - |
dc.contributor.author | Chung, Ik-Joo | - |
dc.contributor.author | Kim, Tae Won | - |
dc.contributor.author | Chun, Hoo Geun | - |
dc.contributor.author | Shin, Dongbok | - |
dc.contributor.author | Kim, Yeul Hong | - |
dc.contributor.author | Song, Hong-Suk | - |
dc.contributor.author | Han, Sae-Won | - |
dc.contributor.author | Kim, Jong Gwang | - |
dc.contributor.author | Kim, Sun Young | - |
dc.contributor.author | Choi, Young Jin | - |
dc.contributor.author | Chung, Hyun Cheol | - |
dc.date.available | 2020-02-29T00:44:19Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2013-02-01 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/14750 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.title | A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000333679000482 | - |
dc.identifier.doi | 10.1200/jco.2013.31.4_suppl.492 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, v.31, no.4 | - |
dc.citation.title | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.citation.volume | 31 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Shin, Dongbok | - |
dc.type.docType | Meeting Abstract | - |
dc.subject.keywordAuthor | Colorectal cancer | - |
dc.subject.keywordAuthor | Chemotherapy | - |
dc.subject.keywordAuthor | TSU-68 | - |
dc.subject.keywordPlus | 1ST-LINE TREATMENT | - |
dc.subject.keywordPlus | PLUS IRINOTECAN | - |
dc.subject.keywordPlus | ORAL S-1 | - |
dc.subject.keywordPlus | BEVACIZUMAB | - |
dc.subject.keywordPlus | FLUOROURACIL | - |
dc.subject.keywordPlus | LEUCOVORIN | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | FOLFIRI | - |
dc.subject.keywordPlus | MARKERS | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.